An interventional study of Acupressure and Sham Acupressure in Postoperative Pain, Postpartum Anxiety and Acupressure, sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. Completed at 1 site in Vietnam. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-10.
Sponsored by University of Medicine and Pharmacy at Ho Chi Minh City · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Pain, Postoperative with a site in Vietnam — 3 open to participants now, 3 under way, none of them phase 3. Pain, Postoperative · Vietnam.
Among the 14 studies in Pain, Postoperative with a site in Vietnam, this one is the 7th largest by enrollment, is one of 3 that started in 2026, is one of 11 with no phase, and was the 13th registered.
5,644 studies on the registry are indexed under Pain, Postoperative; 1,229 are open to participants now.
Browse Pain, Postoperative studies →3 of the 14 studies in Pain, Postoperative with a site in Vietnam are open now. Recruiting first, the newest first:
University of Medicine and Pharmacy at Ho Chi Minh City · Sites in Vietnam
Ages 3–6
Vinmec Healthcare System · Sites in Vietnam
Ages 18–65 · Women only
University Medical Center Ho Chi Minh City (UMC) · Sites in Vietnam
Ages 18+ · Women only
A study can be open while its sites in Vietnam have not opened yet or have stopped. Only those recruiting at a site in Vietnam →
Of the 678 Pain, Postoperative studies recruiting now, 241 (36%) set no upper age limit and 328 (48%) stop at 75 or younger; 74 take children under 18; 128 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 2 · Phase 4 1
First in 2016; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 60 is below the median of 75 across 4,825 interventional studies indexed under Pain, Postoperative.
Median enrollment 60 across the 14 interventional studies. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 14 has an industry lead sponsor. The 8 most frequent:
University of Medicine and Pharmacy at Ho Chi Minh City is the lead sponsor of 127 studies on the registry; 44 are open to participants now.
University of Medicine and Pharmacy at Ho Chi Minh City has 5 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
1 of the studies in Pain, Postoperative with a site in Vietnam that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07615595University Medical Center Ho Chi Minh City (UMC)Dexamethasone to Prevent Side Effects of Spinal Anesthesia in Cesarean Delivery | 2027-07-31 |
Add it to your calendar (.ics) → With an account.
Among the 14 studies in Pain, Postoperative with a site in Vietnam, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to evaluate whether acupressure combined with standard post-operative modern medical care can reduce pain and anxiety in postpartum women after cesarean delivery under spinal anesthesia. The main questions it aims to answer are:
Participants will:
This randomized, single-blind, controlled clinical trial aims to evaluate the effectiveness and safety of acupressure combined with standard modern care in postpartum women with pain and anxiety following cesarean delivery under spinal anesthesia.
Participants who meet the eligibility criteria will be randomly assigned to either the intervention group ( acupressure plus standard modern care) or the control group (sham acupressure plus standard modern care).
In the intervention group, participants will receive manual acupressure (using xoa, day, and an techniques) on three bilateral therapeutic points: Hegu (LI4), Neiguan (PC6), and Sanyinjiao (SP6). Before applying pressure, the surrounding tissue is rubbed (xoa) with the palm for 20-30 seconds. Then, the points are pressed (an) for 5 seconds at a depth of 1-1.5 cm, kneaded (day) for 5 seconds, and rested for 5 seconds, repeating this cycle for 2 minutes per point. The total duration is 15 minutes for 6 points, performed once daily for 3 consecutive days.
In the control group, participants will receive sham acupressure (xoa, day, an) at identical frequencies and durations on 3 non-therapeutic sham points: Sham Hegu, Sham Neiguan, and Sham Sanyinjiao.
Both groups will receive standard post-operative modern pain management as prescribed by the hospital's obstetricians, which includes:
Outcomes including pain (VAS-P), anxiety (VAS-A, STAI-Y1), and any adverse events will be assessed at baseline (T1, pre-intervention) and after 3 days of intervention (T2).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive real acupressure at Hegu (LI4), Neiguan (PC6), and Sanyinjiao (SP6) points for 15 minutes daily over 3 consecutive days post-cesarean section, combined with standard modern medical care.
Procedure: Acupressure · Behavioral: Standard care
Participants receive sham acupressure at non-acupoints for 15 minutes daily over 3 consecutive days post-cesarean section, combined with standard modern medical care.
Procedure: Sham Acupressure · Behavioral: Standard care
Manual massage and acupressure using techniques of rubbing (xoa) for 20-30 seconds, followed by pressing (an) for 5 seconds, kneading (day) for 5 seconds, and resting for 5 seconds, repeating for 2 minutes per point. A total of 15 minutes for 6 bilateral points (Hegu \[LI4\], Neiguan \[PC6\], Sanyinjiao \[SP6\]) will be performed once daily for 3 consecutive days. All procedures will be performed by a licensed traditional medicine physician following standardized protocols.
Sham acupressure using identical techniques (xoa, day, an), duration (3 days), and instructions at 3 bilateral non-therapeutic points: Sham Hegu (on the back of the hand, 1 thon from the midpoint between index and middle fingers), Sham Neiguan (inner forearm, 2 thon from wrist crease and 1.5 thon towards the radial side), and Sham Sanyinjiao (3 thon above the medial malleolus, then 1.5 thon posterior on the Achilles tendon). All procedures will be performed by a licensed traditional medicine physician.
Standard post-operative modern pain management of the hospital: Post-op Day 1: Paracetamol 1g IV q6-8h ± Diclofenac 100mg rectally q12h; Post-op Day 2 onwards: Paracetamol 1g PO q8h ± Diclofenac 100mg rectally q12h or other NSAIDs as prescribed.
Standard post-operative modern pain management of the hospital (identical to the experimental arm).
Change in pain score (Visual Analog Scale for Pain, VAS-P)
Pain is assessed using Visual Analog Scale (VAS-P) ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst possible pain.
Time frame: From baseline (T1, pre-intervention) to Day 3 (T2, post-intervention)
Change in anxiety score (Visual Analog Scale for Anxiety, VAS-A)
Anxiety will be assessed using a 10cm Visual Analog Scale for Anxiety (VAS-A), where 0 indicates no anxiety and 10 indicates extreme anxiety.
Time frame: From baseline (T1, pre-intervention) to Day 3 (T2, post-intervention)
Change in state anxiety score (State-Trait Anxiety Inventory - State scale, STAI-Y1)
State anxiety will be measured using the 20-item STAI-Y1 questionnaire (scores range from 20 to 80, with higher scores indicating higher anxiety).
Time frame: From baseline (T1, pre-intervention) to Day 3 (T2, post-intervention)
Incidence of adverse events related to the intervention
All adverse events (e.g., pain at site, fatigue, bruising, internal bleeding, nerve injury) will be recorded throughout the study period.
Time frame: From baseline (T1, pre-intervention) to Day 3 (T2, post-intervention)
Plan to share: No
No publications or documents are linked to this record.
Ran from Apr 2026 to primary completion in May 2026, 0 months.
Of 2,094 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 0 months is below that.
Counting every sponsor, half of 2,107 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Medicine and Pharmacy at Ho Chi Minh City →